Results 131 to 140 of about 635,296 (203)

SDC4 silencing promotes cell cycle arrest at the restriction point (R point) in anoikis-resistant endothelial cells. [PDF]

Cytotechnology
Ferreira BZF, Pereira DMC, Onyeisi JOS, Machado RS, Tamura RE, Nader HB, Lopes CC.   +6 more
europepmc   +1 more source

Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). [PDF]

Int J Oncol
Aloliqi AA, Alnuqaydan AM, Alshebremi M, Rahmani AH, Khan AA.   +4 more
europepmc   +1 more source

<i>GPR176</i> represses mitophagy to promote the progression of osteosarcoma by facilitating mTORC1 activity via PI3K-AKT pathway. [PDF]

Transl Cancer Res
Jiang J, Zheng B, Wang J, Fang Y, Yang L, Lv J, Liang H.   +6 more
europepmc   +1 more source

A recipe for chaos: Extrachromosomal DNA and the hallmarks of cancer. [PDF]

Cell
Wong IT, Bailey C, Wu S, Henssen AG, Cravatt BF, Chen ZJ, Bafna V, Jamal-Hanjani M, Swanton C, Chang HY, Mischel PS.   +10 more
europepmc   +1 more source

A Unified Model: Chromatin-Bound Multicomponent Condensates. [PDF]

Cancer Res
Lau BK, Haarer EL, Ahn JH, Wang GG.
europepmc   +1 more source

Prediction of Proto-Oncogene Using Bidirectional GRU and Attention. [PDF]

Asian Pac J Cancer Prev
R D S, A BR.
europepmc   +1 more source

EVI1 mediated stimulation of 3T3-L1 preadipocyte differentiation is CtBP dependent [PDF]

, 2017
Al-Hasan, M., Bartholomew, C., Craft, J.A., Graham, A., Ireland, M. J.   +4 more
core   +1 more source

JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK-STAT Signaling Pathway. [PDF]

Cancer Med
Wang X, Luan S, Sun L, Lian L, Qi M.
europepmc   +1 more source

Unsaponifiable fraction of black Vitis vinifera seed oil attenuates liver cancer progression by targeting apoptosis and key tumor-associated genes: In vitro, in vivo, and in silico studies. [PDF]

Sci Rep
Abu-Serie MM, El-Faham AA, Ahmad GM, Habashy NH.   +3 more
europepmc   +1 more source

Synergistic antitumor effect of oroxylin A and donafenib in hepatocellular carcinoma through tumor protein p53 signaling pathway activation. [PDF]

World J Gastroenterol
Zhang MY, Sun RQ, Min Q, Zhu YQ, Qin SK, Guo QL.   +5 more
europepmc   +1 more source